首页> 外文OA文献 >Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysis

【2h】

Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysis

机译：在英国监狱中，增加的丙型肝炎病毒病例发现与当前或8周至12周的直接作用抗病毒治疗相结合是否具有成本效益？预防效益分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Martin Natasha K; Vickerman Peter; Brew Iain F; Williamson Joan; Miners Alec; Irving William L; Saksena Sushma; Hutchinson Sharon J; Mandal Sema; OMoore Eamonn; Hickman Matthew;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
专利

1. Is Increased Hepatitis C Virus Case-Finding Combined With Current or 8-Week to 12-Week Direct-Acting Antiviral Therapy Cost-Effective in UK Prisons? A Prevention Benefit Analysis [J] . Martin Natasha K., Vickerman Peter, Brew Iain F., Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2016,第6期

机译：在英国监狱中，增加的丙型肝炎病毒病例发现与当前或每周8周至12周的直接作用抗病毒治疗的费用有效吗？预防效益分析
2. Safety of Direct-Acting Antiviral Therapy Regarding Renal Function in Post-Liver Transplant Patients Infected with Hepatitis C Virus and a 100% 12-Week Sustained Virologic Response-A Single-Center Study [J] . Peschel G., Moleda L., Baier L., Transplantation Proceedings . 2018,第5期

机译：对肝癌后移植患者肾功能的直接作用抗病毒治疗的安全性，100％12周持续的病毒反应 - 单中心研究
3. What Are the Benefits of a Sustained Virologic Response to Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection? [J] . Ioannou George N., Feld Jordan J. Gastroenterology . 2019,第2期

机译：持续的病毒性反应对丙型肝炎病毒感染的直接作用抗病毒治疗有哪些好处？
4. The Distribution of Change over Time in Metabolic, Inflammatory, and Immune Parameters in HCV-monoinfected and HIV/HCV-coinfected Patients Cured of Hepatitis C Virus by Direct-Acting Antiviral Therapy [D] . Emmanuel, Benjamin. 2018

机译：通过直接作用抗病毒治疗，在HCV-单染料和HCV / HCV / HCV-焦收的患者中的代谢，炎症和免疫参数随时间随时间的分布，通过直接作用抗病毒治疗治愈丙型肝炎病毒
5. IS INCREASED HCV CASE-FINDING COMBINED WITH CURRENT OR 8–12 WEEK DAA THERAPY COST-EFFECTIVE IN UK PRISONS? A PREVENTION BENEFIT ANALYSIS [O] . Natasha K Martin, Peter Vickerman, Iain F Brew, -1

机译：在英国监狱中增加的HCV病例发现与当前或8–12周DAA治疗的成本效益相结合吗？预防效益分析
6. Relation of Reduction of Antibodies against Hepatitis B Virus to Hepatocellular Carcinoma Recurrence in the Patients with Resolved Hepatitis B Virus Infection Following Direct-acting Antiviral Therapy for Hepatitis C Virus Infection [O] . Kouji Joko, Toshie Mashiba, Hironori Ochi, 2019

机译：对乙型肝炎病毒治疗后乙型肝炎病毒感染患者对乙型肝炎病毒对肝细胞癌复发的抗体对肝细胞癌复发的关系

Is increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysis

著录项

引文网络

相似文献

相关主题

期刊订阅